REDWOOD SHORES, Calif., July 16,
2020 /PRNewswire/ -- The National Institute of Allergy
and Infectious Diseases (NIAID), part of the National Institutes of
Health (NIH), recently established the COVID-19 Prevention Network
(CoVPN). Its goal is to register millions of volunteers for
large-scale clinical testing of vaccines and monoclonal antibodies
intended to protect people from COVID-19.
As part of this initiative, Oracle developed a Cloud System
called the CoVPN Volunteer Screening Registry to identify and
screen volunteers who want to participate in COVID-19 clinical
trials. Even though the system has been live for less than a week,
more than 100,000 people have already registered.
This program is expected to support hundreds of clinical trial
sites across the United States and
internationally by the end of the year. The trials are inclusive of
absolutely everyone from all communities, with a focus on those who
are at higher risk for COVID-19. We encourage you to visit the
CoVPN website, learn more about the vaccine trial program, and
volunteer if you are able at http://covpn.oracle.com/survey.
Oracle is Helping in the COVID-19 Fight
The CoVPN
Volunteer Screening Registry in the latest in a series of COVID-19
cloud application systems built by Oracle to support the U.S.
Department of Health and Human Services (HHS), healthcare providers
and medical researchers. Taken together, these systems are designed
to enable health professionals to collect and analyze the data
necessary to better understand and combat COVID-19.
In April, Oracle developed a Therapeutic Learning
System (TLS) that allows physicians and patients to record
responses to promising COVID-19 drug therapies. In partnership with
health systems such as Wake Forest Baptist Health and Javara
Research, the initiative was extended to include patient
monitoring. Participating patients can easily log their symptoms on
smartphones giving healthcare professionals immediate access to
early warning signs. Over 1.5 million patient updates have
already been recorded in TLS.
With today's announcement, Oracle is expanding its cooperation
with HHS to support the large-scale clinical trials required in the
race for a vaccine.
To learn more about how Oracle is helping countless industries
navigate COVID-19, visit:
https://www.oracle.com/corporate/covid-19.html
About Oracle
The Oracle Cloud offers Highly Automated
and Secure Infrastructure featuring the Oracle Autonomous Database.
For more information about Oracle (NYSE: ORCL), please visit us at
www.oracle.com.
Trademark
Oracle and Java are registered trademarks of
Oracle and/or its affiliates. Other names may be trademarks of
their respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/oracle-and-nih-collaborate-on-cloud-system-to-support-covid-19-vaccine-trials-301095159.html
SOURCE Oracle Corporation